XOMA Corp. Reaches New 12-Month High at $7.47 (XOMA)
XOMA Corp. (NASDAQ:XOMA)’s share price reached a new 52-week high during trading on Wednesday, Analyst Ratings News reports. The stock traded as high as $7.47 and last traded at $7.20, with a volume of 1,628,025 shares traded. The stock had previously closed at $7.00.
A number of research firms have recently commented on XOMA. Analysts at Roth Capital raised their price target on shares of XOMA Corp. from $6.00 to $8.00 in a research note to investors on Friday, November 1st. They now have a “buy” rating on the stock. Separately, analysts at Credit Suisse raised their price target on shares of XOMA Corp. from $5.00 to $8.00 in a research note to investors on Friday, November 1st. They now have an “outperform” rating on the stock. Finally, analysts at RBC Capital raised their price target on shares of XOMA Corp. from $7.00 to $9.00 in a research note to investors on Thursday, October 31st. They now have an “outperform” rating on the stock. Seven analysts have rated the stock with a buy rating, XOMA Corp. currently has an average rating of “Buy” and an average price target of $7.63.
XOMA Corp. has a 52-week low of $2.46 and a 52-week high of $7.45. The stock has a 50-day moving average of $5.80 and a 200-day moving average of $4.81. The company’s market cap is $666.4 million.
XOMA Corp. (NASDAQ:XOMA) last released its earnings data on Thursday, November 7th. The company reported ($0.21) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.18) by $0.03. The company had revenue of $6.31 million for the quarter, compared to the consensus estimate of $7.87 million. During the same quarter last year, the company posted ($0.39) earnings per share. XOMA Corp.’s revenue was down 13.0% compared to the same quarter last year. On average, analysts predict that XOMA Corp. will post $-1.05 earnings per share for the current fiscal year.
XOMA Corporation (NASDAQ:XOMA) is engaged in the discovery and development of antibody-based therapeutics.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.